Therapy for Erectile Dysfunction Adaptation of ACT for Compliance With an Erectile Rehabilitation Program
Completed · Not applicable
Conditions studied: Prostate Cancer
In brief
The investigators know that treatment for prostate cancer and erectile dysfunction can impact sexual health and quality of life. They want to learn how the treatment affects one's emotional and social well-being. They have developed a new type of counseling. Cancer patients seek counseling for lots of reasons. It often helps them cope because they can express their feelings with a trained professional. They hope that this counseling will teach patients skills that they can use to comply with erectile treatment programs, improve their sexual health and quality of life. These skills may also improve physical and emotional well-being. As part of this study they will ask the patient to provide feedback on the proposed counseling.
Key facts
- Study ID
- NCT01275404
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 99
- Starts
- 2010-12-28
- Expected to finish
- 2019-07-10
- Last updated by the study team
- 2019-07-15
Who can join
Age: 21 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Part A
- Men who are 1 to 3 years post radical prostatectomy for early stage prostate cancer
- Participated in penile injection program
- Are able to speak, read, write and understand English well enough to complete study assessment and communicate with an English speaking therapist
- Part B
- Men who are up to 9 months post radical prostatectomy.
- Had good erectile functioning pre-surgery (i.e., 24 or greater on the IIEF Erectile Function Domain (EFD) score), graded their erections as a 1 or 2 on the standard 5 point Urology Erectile Function scale) or have a score of 7 or greater on the 1-10 pre-surgery erectile function scale on the SMRP assessment)
- Seen at MSKCC"s Sexual Medicine Rehabilitation Program (SMRP)
- Advised by the clinical staff of the SMRP to start penile injections.
You may not qualify if…
- Part A
- Recurrence or progression of disease,
- Specific injection phobia (self report)
- A history of bipolar disorder or psychotic disorder (determined from self-report and/or chart review)
- Current major depression (determined by self report and/or clinician observation and assessment) that would preclude from giving informed consent or being an active participant in a focus group
- Part B
- Specific injection phobia (self report)
- A history of bipolar disorder or psychotic disorder (determined from self-report and/or chart review)
- Current major depression (determined by self report and/or clinician observation and assessment) that would preclude from giving informed consent or being an active participant in a therapeutic session.
Where it is running
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.